<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35059730</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1791-244X</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>International journal of molecular medicine</Title><ISOAbbreviation>Int J Mol Med</ISOAbbreviation></Journal><ArticleTitle>Thrombocytopenia in COVID&#x2011;19 and vaccine&#x2011;induced thrombotic thrombocytopenia.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">35</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3892/ijmm.2022.5090</ELocationID><Abstract><AbstractText>The highly heterogeneous symptomatology and unpredictable progress of COVID&#x2011;19 triggered unprecedented intensive biomedical research and a number of clinical research projects. Although the pathophysiology of the disease is being progressively clarified, its complexity remains vast. Moreover, some extremely infrequent cases of thrombotic thrombocytopenia following vaccination against SARS&#x2011;CoV&#x2011;2 infection have been observed. The present study aimed to map the signaling pathways of thrombocytopenia implicated in COVID&#x2011;19, as well as in vaccine&#x2011;induced thrombotic thrombocytopenia (VITT). The biomedical literature database, MEDLINE/PubMed, was thoroughly searched using artificial intelligence techniques for the semantic relations among the top&#xa0;50 similar words (&gt;0.9) implicated in COVID&#x2011;19&#x2011;mediated human infection or VITT. Additionally, STRING, a database of primary and predicted associations among genes and proteins (collected from diverse resources, such as documented pathway knowledge, high&#x2011;throughput experimental studies, cross&#x2011;species extrapolated information, automated text mining results, computationally predicted interactions, etc.), was employed, with the confidence threshold set at&#xa0;0.7. In addition, two interactomes were constructed: i)&#xa0;A&#xa0;network including 119&#xa0;and&#xa0;56&#xa0;nodes relevant to COVID&#x2011;19 and thrombocytopenia, respectively; and ii)&#xa0;a second network containing 60&#xa0;nodes relevant to VITT. Although thrombocytopenia is a dominant morbidity in both entities, three nodes were observed that corresponded to genes (AURKA, CD46 and CD19) expressed only in VITT, whilst ADAM10, CDC20, SHC1 and STXBP2 are silenced in VITT, but are commonly expressed in both COVID&#x2011;19 and thrombocytopenia. The calculated average node degree was immense (11.9&#xa0;in COVID&#x2011;19 and 6.43&#xa0;in VITT), illustrating the complexity of COVID&#x2011;19 and VITT pathologies and confirming the importance of cytokines, as well as of pathways activated following hypoxic events. In addition, PYCARD, NLP3 and P2RX7 are key potential therapeutic targets for all three morbid entities, meriting further research. This interactome was based on wild&#x2011;type genes, revealing the predisposition of the body to hypoxia&#x2011;induced thrombosis, leading to the acute COVID&#x2011;19 phenotype, the 'long&#x2011;COVID syndrome', and/or VITT. Thus, common nodes appear to be key players in illness prevention, progression and treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Geronikolou</LastName><ForeName>Styliani A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Clinical, Translational and Experimental Surgery Research Centre, Biomedical Research Foundation Academy of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takan</LastName><ForeName>I&#x15f;il</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Izmir Biomedicine and Genome Center (IBG), 35340 Izmir, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavlopoulou</LastName><ForeName>Athanasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Izmir Biomedicine and Genome Center (IBG), 35340 Izmir, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mantzourani</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>First Department of Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens Medical School, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chrousos</LastName><ForeName>George P</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>Clinical, Translational and Experimental Surgery Research Centre, Biomedical Research Foundation Academy of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Int J Mol Med</MedlineTA><NlmUniqueID>9810955</NlmUniqueID><ISSNLinking>1107-3756</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013921" MajorTopicYN="Y">Thrombocytopenia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2011;19</Keyword><Keyword MajorTopicYN="N">HLA system</Keyword><Keyword MajorTopicYN="N">SARS&#x2011;CoV&#x2011;2</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">cytokine storm</Keyword><Keyword MajorTopicYN="N">enzymes</Keyword><Keyword MajorTopicYN="N">interactions network</Keyword><Keyword MajorTopicYN="N">lymphocytes</Keyword><Keyword MajorTopicYN="N">natural language processing</Keyword><Keyword MajorTopicYN="N">thrombocytopenia</Keyword><Keyword MajorTopicYN="N">vaccine&#x2011;induced thrombotic thrombocytopenia</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35059730</ArticleId><ArticleId IdType="pmc">PMC8815408</ArticleId><ArticleId IdType="doi">10.3892/ijmm.2022.5090</ArticleId><ArticleId IdType="pii">35</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization (WHO) Coronovirus disease (COVID-19): Vaccines safety. WHO; Geneva: 2021.</Citation></Reference><Reference><Citation>Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384:2092&#x2013;2101. doi: 10.1056/NEJMoa2104840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2104840</ArticleId><ArticleId IdType="pmc">PMC8095372</ArticleId><ArticleId IdType="pubmed">33835769</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, Giattino C, Rod&#xe9;s-Guirao L. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021;5:947&#x2013;953. doi: 10.1038/s41562-021-01122-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-021-01122-8</ArticleId><ArticleId IdType="pubmed">33972767</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei CH, Allot A, Leaman R, Lu Z. PubTator central: Automated concept annotation for biomedical full text articles. Nucleic Acids Res. 2019;47(W1):W587&#x2013;W593. doi: 10.1093/nar/gkz389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz389</ArticleId><ArticleId IdType="pmc">PMC6602571</ArticleId><ArticleId IdType="pubmed">31114887</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Allot A, Lu Z. LitCovid: An open database of COVID-19 literature. Nucleic Acids Res. 2021;49(D1):D1534&#x2013;D1540. doi: 10.1093/nar/gkaa952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa952</ArticleId><ArticleId IdType="pmc">PMC7778958</ArticleId><ArticleId IdType="pubmed">33166392</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607&#x2013;D613. doi: 10.1093/nar/gky1131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1131</ArticleId><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, et al. The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605&#x2013;D612. doi: 10.1093/nar/gkaa1074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1074</ArticleId><ArticleId IdType="pmc">PMC7779004</ArticleId><ArticleId IdType="pubmed">33237311</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498&#x2013;2504. doi: 10.1101/gr.1239303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith Wesley D., editor. Loeb Classical Library 477. Harvard University Press; Cambridge, MA: 1994. Hippocrates: Epidemics 2, 4-7.</Citation></Reference><Reference><Citation>Jouanna J. Hippocrates. John Hopkins University Press; Baltimore, MD: 1999.</Citation></Reference><Reference><Citation>Mammas IN, Spandidos DA. Paediatric virology in the Hippocratic corpus. Exp Ther Med. 2016;12:541&#x2013;549. doi: 10.3892/etm.2016.3420.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2016.3420</ArticleId><ArticleId IdType="pmc">PMC4950906</ArticleId><ArticleId IdType="pubmed">27446241</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappas G, Kiriaze IJ, Falagas ME. Insights into infectious disease in the era of Hippocrates. Int J Infect Dis. 2008;12:347&#x2013;350. doi: 10.1016/j.ijid.2007.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2007.11.003</ArticleId><ArticleId IdType="pubmed">18178502</ArticleId></ArticleIdList></Reference><Reference><Citation>Misselbrook D. Aristotle, hume and the goals of medicine. J Eval Clin Pract. 2016;22:544&#x2013;549. doi: 10.1111/jep.12371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jep.12371</ArticleId><ArticleId IdType="pubmed">25851463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulff HR. The concept of disease: From Newton back to Aristotle. Lancet. 1999;354(Suppl):SIV50. doi: 10.1016/S0140-6736(99)90393-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(99)90393-8</ArticleId><ArticleId IdType="pubmed">10691464</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulff HR. The concept of disease: From Newton back to Aristotle. Lancet. 1999;54:354.</Citation><ArticleIdList><ArticleId IdType="pubmed">10691464</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz EN. Deterministic nonperiodic flow. J Atmos Sci. 1963;20:130&#x2013;141. doi: 10.1175/1520-0469(1963)020&lt;0130:DNF&gt;2.0.CO;2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1175/1520-0469(1963)020&lt;0130:DNF&gt;2.0.CO;2</ArticleId></ArticleIdList></Reference><Reference><Citation>Barab&#xe1;si AL, Gulbahce N, Loscalzo J. Network medicine: A network-based approach to human disease. Nat Rev Genet. 2011;12:56&#x2013;68. doi: 10.1038/nrg2918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2918</ArticleId><ArticleId IdType="pmc">PMC3140052</ArticleId><ArticleId IdType="pubmed">21164525</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199&#x2013;1207. doi: 10.1056/NEJMoa2001316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001316</ArticleId><ArticleId IdType="pmc">PMC7121484</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>Raoult D, Zumla A, Locatelli F, Ippolito G, Kroemer G. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses. Cell Stress. 2020;4:66&#x2013;75. doi: 10.15698/cst2020.04.216.</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/cst2020.04.216</ArticleId><ArticleId IdType="pmc">PMC7064018</ArticleId><ArticleId IdType="pubmed">32292881</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal S, Quintili AL, Karamchandani K, Bose S. Thromboembolic disease in COVID-19 patients: A brief narrative review. J Intensive Care. 2020;8:70. doi: 10.1186/s40560-020-00483-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-020-00483-y</ArticleId><ArticleId IdType="pmc">PMC7487447</ArticleId><ArticleId IdType="pubmed">32939266</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99:1205&#x2013;1208. doi: 10.1007/s00277-020-04019-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-020-04019-0</ArticleId><ArticleId IdType="pmc">PMC7156897</ArticleId><ArticleId IdType="pubmed">32296910</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450&#x2013;454. doi: 10.1038/nature02145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02145</ArticleId><ArticleId IdType="pmc">PMC7095016</ArticleId><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, Epstein JH, Mazet JK, Hu B, Zhang W, Peng C, et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013;503:535&#x2013;538. doi: 10.1038/nature12711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12711</ArticleId><ArticleId IdType="pmc">PMC5389864</ArticleId><ArticleId IdType="pubmed">24172901</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, Mencarini J, Caporale R, Peruzzi B, Antonelli A, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020;130:4694&#x2013;4703. doi: 10.1172/JCI138554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI138554</ArticleId><ArticleId IdType="pmc">PMC7456250</ArticleId><ArticleId IdType="pubmed">32463803</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama IE, Ravera A, Santema BT, van Goor H, Ter Maaten JM, Cleland JGF, Rienstra M, Friedrich AW, Samani NJ, Ng LL, et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020;41:1810&#x2013;1817. doi: 10.1093/eurheartj/ehaa373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa373</ArticleId><ArticleId IdType="pmc">PMC7239195</ArticleId><ArticleId IdType="pubmed">32388565</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz JH. Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J Travel Med. 2020;27:taaa041. doi: 10.1093/jtm/taaa041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taaa041</ArticleId><ArticleId IdType="pmc">PMC7184445</ArticleId><ArticleId IdType="pubmed">32186711</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;18:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao T, Hu M, Zhang X, Li H, Zhu L, Liu H, Dong Q, Zhang Z, Wang Z, Hu Y, et al. Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation. medRxiv. 2020 ppmedrxiv-20041962.</Citation></Reference><Reference><Citation>Cao X. COVID-19: Immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20:269&#x2013;270. doi: 10.1038/s41577-020-0308-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0308-3</ArticleId><ArticleId IdType="pmc">PMC7143200</ArticleId><ArticleId IdType="pubmed">32273594</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, Perlman S. Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39:529&#x2013;539. doi: 10.1007/s00281-017-0629-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0629-x</ArticleId><ArticleId IdType="pmc">PMC7079893</ArticleId><ArticleId IdType="pubmed">28466096</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Zhao J, Perlman S. T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice. J Virol. 2010;84:9318&#x2013;9325. doi: 10.1128/JVI.01049-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01049-10</ArticleId><ArticleId IdType="pmc">PMC2937604</ArticleId><ArticleId IdType="pubmed">20610717</ArticleId></ArticleIdList></Reference><Reference><Citation>Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest. 1995;108:1303&#x2013;1314. doi: 10.1378/chest.108.5.1303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.108.5.1303</ArticleId><ArticleId IdType="pubmed">7587434</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844&#x2013;847. doi: 10.1111/jth.14768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med. 2020;46:1089&#x2013;1098. doi: 10.1007/s00134-020-06062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06062-x</ArticleId><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145&#x2013;147. doi: 10.1016/j.thromres.2020.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JC. Hemostasis based on a novel 'two-path unifying theory' and classification of hemostatic disorders. Blood Coagul Fibrinolysis. 2018;29:573&#x2013;584. doi: 10.1097/MBC.0000000000000765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0000000000000765</ArticleId><ArticleId IdType="pubmed">30063477</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JC. Sepsis and septic shock: Endothelial molecular pathogenesis associated with vascular microthrombotic disease. Thromb J. 2019;17:10. doi: 10.1186/s12959-019-0198-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12959-019-0198-4</ArticleId><ArticleId IdType="pmc">PMC6542012</ArticleId><ArticleId IdType="pubmed">31160889</ArticleId></ArticleIdList></Reference><Reference><Citation>Seirafianpour F, Sodagar S, Pour Mohammad A, Panahi P, Mozafarpoor S, Almasi S, Goodarzi A. Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review. Dermatol Ther. 2020;33:e13986. doi: 10.1111/dth.13986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dth.13986</ArticleId><ArticleId IdType="pmc">PMC7362033</ArticleId><ArticleId IdType="pubmed">32639077</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan DE. PAI-1 and atherothrombosis. J Thromb Haemost. 2005;3:1879&#x2013;1883. doi: 10.1111/j.1538-7836.2005.01420.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2005.01420.x</ArticleId><ArticleId IdType="pubmed">16102055</ArticleId></ArticleIdList></Reference><Reference><Citation>Badary OA. Pharmacogenomics and COVID-19: Clinical implications of human genome interactions with repurposed drugs. Pharmacogenomics J. 2021;21:275&#x2013;284. doi: 10.1038/s41397-021-00209-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41397-021-00209-9</ArticleId><ArticleId IdType="pmc">PMC7859465</ArticleId><ArticleId IdType="pubmed">33542445</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MR, Kuo HC, Lee YJ, Chi H, Li SC, Lee HC, Yang KD. Phenotype, susceptibility, autoimmunity, and immunotherapy between Kawasaki disease and coronavirus disease-19 associated multisystem inflammatory syndrome in children. Front Immunol. 2021;12:632890. doi: 10.3389/fimmu.2021.632890.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.632890</ArticleId><ArticleId IdType="pmc">PMC7959769</ArticleId><ArticleId IdType="pubmed">33732254</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-L&#xf3;pez JP, Carnalla-Cort&#xe9;s M, Pacheco-Olvera DL, Ocampo-God&#xed;nez JM, Oliva-Ram&#xed;rez J, Moreno-Manj&#xf3;n J, Bernal-Alferes B, L&#xf3;pez-Olmedo N, Garc&#xed;a-Latorre E, Dom&#xed;nguez-L&#xf3;pez ML, et al. A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theoretical correlation of HLA-DRB1*01 with COVID-19 fatality in Mexican population: An ecological approach. J Med Virol. 2021;93:2029&#x2013;2038. doi: 10.1002/jmv.26561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26561</ArticleId><ArticleId IdType="pmc">PMC7537233</ArticleId><ArticleId IdType="pubmed">32986250</ArticleId></ArticleIdList></Reference><Reference><Citation>Anzurez A, Naka I, Miki S, Nakayama-Hosoya K, Isshiki M, Watanabe Y, Nakamura-Hoshi M, Seki S, Matsumura T, Takano T, et al. Association of HLA-DRB1*09:01 with severe COVID-19. HLA. 2021;98:37&#x2013;42. doi: 10.1111/tan.14256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tan.14256</ArticleId><ArticleId IdType="pmc">PMC8251239</ArticleId><ArticleId IdType="pubmed">33734601</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotondo JC, Bosi S, Bassi C, Ferracin M, Lanza G, Gaf&#xe0; R, Magri E, Selvatici R, Torresani S, Marci R, et al. Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes. J Cell Physiol. 2015;230:806&#x2013;812. doi: 10.1002/jcp.24808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.24808</ArticleId><ArticleId IdType="pubmed">25205602</ArticleId></ArticleIdList></Reference><Reference><Citation>Combs AP. Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer. J Med Chem. 2010;53:2333&#x2013;2344. doi: 10.1021/jm901090b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm901090b</ArticleId><ArticleId IdType="pubmed">20000419</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239&#x2013;247. doi: 10.1038/35041687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35041687</ArticleId><ArticleId IdType="pubmed">11089981</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi YM, Kwon HS, Choi KM, Lee WY, Hong EG. Short-term effects of beraprost sodium on the markers for cardiovascular risk prediction in type 2 diabetic patients with microalbuminuria. Endocrinol Metab (Seoul) 2019;34:398&#x2013;405. doi: 10.3803/EnM.2019.34.4.398.</Citation><ArticleIdList><ArticleId IdType="doi">10.3803/EnM.2019.34.4.398</ArticleId><ArticleId IdType="pmc">PMC6935783</ArticleId><ArticleId IdType="pubmed">31884740</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura S, Taniura T, Shouzu A, Omoto S, Suzuki M, Okuda Y, Ito T. Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study) Vasc Health Risk Manag. 2018;14:225&#x2013;232. doi: 10.2147/VHRM.S171143.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/VHRM.S171143</ArticleId><ArticleId IdType="pmc">PMC6151091</ArticleId><ArticleId IdType="pubmed">30271161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Liu SQ, Sun Q, Xie JF, Xu JY, Li Q, Pan C, Liu L, Huang YZ. Plasma microRNAs levels are different between pulmonary and extrapulmonary ARDS patients: A clinical observational study. Ann Intensive Care. 2018;8:23. doi: 10.1186/s13613-018-0370-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-018-0370-1</ArticleId><ArticleId IdType="pmc">PMC5811418</ArticleId><ArticleId IdType="pubmed">29442256</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia EF, Jolley SE, Crothers K, Schnapp LM, Liles WC. Soluble vascular cell adhesion molecule-1 (sVCAM-1) is elevated in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. PLoS One. 2016;11:e0149687. doi: 10.1371/journal.pone.0149687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0149687</ArticleId><ArticleId IdType="pmc">PMC4768838</ArticleId><ArticleId IdType="pubmed">26919714</ArticleId></ArticleIdList></Reference><Reference><Citation>Cines DB, Bussel JB. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. N Engl J Med. 2021;384:2254&#x2013;2256. doi: 10.1056/NEJMe2106315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2106315</ArticleId><ArticleId IdType="pmc">PMC8063912</ArticleId><ArticleId IdType="pubmed">33861524</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz NH, S&#xf8;rvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, Wiedmann M, Aamodt AH, Skatt&#xf8;r TH, Tj&#xf8;nnfjord GE, Holme PA. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021;384:2124&#x2013;2130. doi: 10.1056/NEJMoa2104882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2104882</ArticleId><ArticleId IdType="pmc">PMC8112568</ArticleId><ArticleId IdType="pubmed">33835768</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency (EMA) COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events-vaccine's benefits currently still outweigh risks-update. 2021</Citation></Reference><Reference><Citation>World Health Organization (WHO) Statement of the WHO global advisory committee on vaccine safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine. WHO; Geneva: 2021.</Citation></Reference><Reference><Citation>Bussel JB, Connors JM, Cines DB, Dunbar CE, Michaelis LC, Kreuziger LB, Lee AYY, Pabinger-Fasching I. Thrombosis with thrombocytopenia syndrome (also termed vaccine-induced thrombotic thrombocytopenia) American Society of Haematology; Washington, DC: 2021.</Citation></Reference><Reference><Citation>Thaler J, Ay C, Gleixner KV, Hauswirth AW, Cacioppo F, Grafeneder J, Quehenberger P, Pabinger I, Kn&#xf6;bl P. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) J Thromb Haemost. 2021;19:1819&#x2013;1822. doi: 10.1111/jth.15346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15346</ArticleId><ArticleId IdType="pmc">PMC8362082</ArticleId><ArticleId IdType="pubmed">33877735</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadja DM, Mentzer SJ, Fontenay M, Laffan MA, Ackermann M, Helms J, Jonigk D, Chocron R, Pier GB, Gendron N, et al. COVID-19 is a systemic vascular hemopathy: Insight for mechanistic and clinical aspects. Angiogenesis. 2021;24:755&#x2013;788. doi: 10.1007/s10456-021-09805-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-021-09805-6</ArticleId><ArticleId IdType="pmc">PMC8238037</ArticleId><ArticleId IdType="pubmed">34184164</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashir J, Ambia AR, Shafqat A, Sajid MR, AlKattan K, Yaqinuddin A. Scientific premise for the involvement of neutrophil extracellular traps (NETs) in vaccine-induced thrombotic thrombocytopenia (VITT) J Leukoc Biol. 2021 Sep 1; doi: 10.1002/JLB.5COVR0621-320RR. Epub ahead of prin.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.5COVR0621-320RR</ArticleId><ArticleId IdType="pmc">PMC8667645</ArticleId><ArticleId IdType="pubmed">34467562</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta N, Sahu A, Prabhakar A, Chatterjee T, Tyagi T, Kumari B, Khan N, Nair V, Bajaj N, Sharma M, Ashraf MZ. Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia. Proc Natl Acad Sci USA. 2017;114:4763&#x2013;4768. doi: 10.1073/pnas.1620458114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1620458114</ArticleId><ArticleId IdType="pmc">PMC5422823</ArticleId><ArticleId IdType="pubmed">28420787</ArticleId></ArticleIdList></Reference><Reference><Citation>Salaro E, Rambaldi A, Falzoni S, Amoroso FS, Franceschini A, Sarti AC, Bonora M, Cavazzini F, Rigolin GM, Ciccone M, et al. Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death. Sci Rep. 2016;6:26280. doi: 10.1038/srep26280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep26280</ArticleId><ArticleId IdType="pmc">PMC4879576</ArticleId><ArticleId IdType="pubmed">27221966</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro DE, Oliveira-Giacomelli &#xc1;, Glaser T, Arnaud-Sampaio VF, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry. 2021;26:1044&#x2013;1059. doi: 10.1038/s41380-020-00965-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-00965-3</ArticleId><ArticleId IdType="pmc">PMC7738776</ArticleId><ArticleId IdType="pubmed">33328588</ArticleId></ArticleIdList></Reference><Reference><Citation>Savio LEB, de Andrade Mello P, da Silva CG, Coutinho-Silva R. The P2X7 receptor in inflammatory diseases: Angel or demon. Front Pharmacol. 2018;9:52. doi: 10.3389/fphar.2018.00052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00052</ArticleId><ArticleId IdType="pmc">PMC5808178</ArticleId><ArticleId IdType="pubmed">29467654</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco PAF, Faria RX. The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target? Scand J Immunol. 2021;93:e12960. doi: 10.1111/sji.12960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12960</ArticleId><ArticleId IdType="pmc">PMC7461012</ArticleId><ArticleId IdType="pubmed">32797724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz GG, Pacheco-Mois&#xe9;s FP, Mac&#xed;as-Islas M, Flores-Alvarado LJ, Mireles-Ram&#xed;rez MA, Gonz&#xe1;lez-Renovato ED, Her n&#xe1;ndez-Nava r ro VE. Role of the blood-brain barrier in multiple sclerosis. Arch Med Res. 2014;45:687&#x2013;697. doi: 10.1016/j.arcmed.2014.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2014.11.013</ArticleId><ArticleId IdType="pubmed">25431839</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Virgilio F, Tang Y, Sarti AC, Rossato M. A rationale for targeting the P2X7 receptor in coronavirus disease 19. Br J Pharmacol. 2020;177:4990&#x2013;4994. doi: 10.1111/bph.15138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15138</ArticleId><ArticleId IdType="pmc">PMC7280564</ArticleId><ArticleId IdType="pubmed">32441783</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira AC, Soares VC, de Azevedo-Quintanilha IG, Dias SDSG, Fintelman-Rodrigues N, Sacramento CQ, Mattos M, de Freitas CS, Temerozo JR, Teixeira L, et al. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discov. 2021;7:43. doi: 10.1038/s41420-021-00428-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00428-w</ArticleId><ArticleId IdType="pmc">PMC7919254</ArticleId><ArticleId IdType="pubmed">33649297</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss ML, Bartsch JW. Therapeutic benefits from targeting of ADAM family members. Biochemistry. 2004;43:7227&#x2013;7235. doi: 10.1021/bi049677f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi049677f</ArticleId><ArticleId IdType="pubmed">15182168</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza JSM, Lisboa ABP, Santos TM, Andrade MVS, Neves VBS, Teles-Souza J, Jesus HNR, Bezerra TG, Falc&#xe3;o VGO, Oliveira RC, Del-Bem LE. The evolution of ADAM gene family in eukaryotes. Genomics. 2020;112:3108&#x2013;3116. doi: 10.1016/j.ygeno.2020.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2020.05.010</ArticleId><ArticleId IdType="pubmed">32437852</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Xu X, Jiang L, Dua K, Hansbro PM, Liu G. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis. Respir Res. 2020;21:182. doi: 10.1186/s12931-020-01445-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01445-6</ArticleId><ArticleId IdType="pmc">PMC7359430</ArticleId><ArticleId IdType="pubmed">32664949</ArticleId></ArticleIdList></Reference><Reference><Citation>Katneni UK, Alexaki A, Hunt RC, Schiller T, DiCuccio M, Buehler PW, Ibla JC, Kimchi-Sarfaty C. Coagulopathy and thrombosis as a result of severe COVID-19 infection: A microvascular focus. Thromb Haemost. 2020;120:1668&#x2013;1679. doi: 10.1055/s-0040-1715841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1715841</ArticleId><ArticleId IdType="pmc">PMC7869056</ArticleId><ArticleId IdType="pubmed">32838472</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J, Sun D, Xie Y, Liu K, Ma Y. Network pharmacology-based study of the molecular mechanisms of Qixuekang in treating COVID-19 during the recovery period. Int J Clin Exp Pathol. 2020;13:2677&#x2013;2690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7642714</ArticleId><ArticleId IdType="pubmed">33165417</ArticleId></ArticleIdList></Reference><Reference><Citation>Boron WF, Boulpaep EL. Medical physiology: A cellular and molecular approach. Saunders Elsevier; Philadelphia, PA: 2012.</Citation></Reference><Reference><Citation>Fitzpatrick D, Purves D, Augustine G. Neuroscience. 3rd edition. Sinauer Associates, Inc; Sunderland, MA: 2004.</Citation></Reference><Reference><Citation>Wang Q, Zhu W, Xiao G, Ding M, Chang J, Liao H. Effect of AGER on the biological behavior of non-small cell lung cancer H1299 cells. Mol Med Rep. 2020;22:810&#x2013;818. doi: 10.3892/mmr.2020.11176.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2020.11176</ArticleId><ArticleId IdType="pmc">PMC7339481</ArticleId><ArticleId IdType="pubmed">32468030</ArticleId></ArticleIdList></Reference><Reference><Citation>Man SM, Karki R, Kanneganti TD. AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunity. Eur J Immunol. 2016;46:269&#x2013;280. doi: 10.1002/eji.201545839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201545839</ArticleId><ArticleId IdType="pmc">PMC4758349</ArticleId><ArticleId IdType="pubmed">26626159</ArticleId></ArticleIdList></Reference><Reference><Citation>Bafunno V, Firinu D, D'Apolito M, Cordisco G, Loffredo S, Leccese A, Bova M, Barca MP, Santacroce R, Cicardi M, et al. Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema. J Allergy Clin Immunol. 2018;141:1009&#x2013;1017. doi: 10.1016/j.jaci.2017.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.05.020</ArticleId><ArticleId IdType="pubmed">28601681</ArticleId></ArticleIdList></Reference><Reference><Citation>PubMed Gene database: ANGPT2 angiopoietin 2 [Homo sapiens (human)]   https://www.ncbi.nlm.nih.gov/gene?Db=gene&amp;Cmd=ShowDetailView&amp;TermToSearch=285 Accessed December 12, 2020.</Citation></Reference><Reference><Citation>Marumoto T, Honda S, Hara T, Nitta M, Hirota T, Kohmura E, Saya H. Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells. J Biol Chem. 2003;278:51786&#x2013;51795. doi: 10.1074/jbc.M306275200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M306275200</ArticleId><ArticleId IdType="pubmed">14523000</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Zhang J, Liao D, Yang L, Wang Y, Hou S. Association between C4, C4A, and C4B copy number variations and susceptibility to autoimmune diseases: A meta-analysis. Sci Rep. 2017;7:42628. doi: 10.1038/srep42628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42628</ArticleId><ArticleId IdType="pmc">PMC5311832</ArticleId><ArticleId IdType="pubmed">28205620</ArticleId></ArticleIdList></Reference><Reference><Citation>Horiuchi T, Tsukamoto H. Complement-targeted therapy: Development of C5- and C5a-targeted inhibition. Inflamm Regen. 2016;36:11. doi: 10.1186/s41232-016-0013-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41232-016-0013-6</ArticleId><ArticleId IdType="pmc">PMC5725830</ArticleId><ArticleId IdType="pubmed">29259684</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobart MJ, Fernie BA, DiScipio RG. Structure of the human C7 gene and comparison with the C6, C8A, C8B, and C9 genes. J Immunol. 1995;154:5188&#x2013;5194.</Citation><ArticleIdList><ArticleId IdType="pubmed">7730625</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia S, Zhang Z, Magupalli VG, Pablo JL, Dong Y, Vora SM, Wang L, Fu TM, Jacobson MP, Greka A, et al. Gasdermin D pore structure reveals preferential release of mature interleukin-1. Nature. 2021;593:607&#x2013;611. doi: 10.1038/s41586-021-03478-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03478-3</ArticleId><ArticleId IdType="pmc">PMC8588876</ArticleId><ArticleId IdType="pubmed">33883744</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen GM. Caspases: The executioners of apoptosis. Biochem J. 1997;326:1&#x2013;16. doi: 10.1042/bj3260001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3260001</ArticleId><ArticleId IdType="pmc">PMC1218630</ArticleId><ArticleId IdType="pubmed">9337844</ArticleId></ArticleIdList></Reference><Reference><Citation>Avrutsky MI, Troy CM. Caspase-9: A multimodal therapeutic target with diverse cellular expression in human disease. Front Pharmacol. 2021;12:701301. doi: 10.3389/fphar.2021.701301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.701301</ArticleId><ArticleId IdType="pmc">PMC8299054</ArticleId><ArticleId IdType="pubmed">34305609</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Anshita D, Ravichandiran V. MCP-1: Function, regulation, and involvement in disease. Int Immunopharmacol. 2021;101:107598. doi: 10.1016/j.intimp.2021.107598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107598</ArticleId><ArticleId IdType="pmc">PMC8135227</ArticleId><ArticleId IdType="pubmed">34233864</ArticleId></ArticleIdList></Reference><Reference><Citation>Coperchini F, Chiovato L, Ricci G, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved. Cytokine Growth Factor Rev. 2021;58:82&#x2013;91. doi: 10.1016/j.cytogfr.2020.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC7837329</ArticleId><ArticleId IdType="pubmed">33573850</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan E, Wang J, Norcross MA. Identification of human macrophage inflammatory proteins 1alpha and 1beta as a native secreted heterodimer. J Biol Chem. 2001;276:12404&#x2013;12409. doi: 10.1074/jbc.M006327200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M006327200</ArticleId><ArticleId IdType="pubmed">11278300</ArticleId></ArticleIdList></Reference><Reference><Citation>Charrier A, Brigstock DR. Regulation of pancreatic function by connective tissue growth factor (CTGF, CCN2) Cytokine Growth Factor Rev. 2013;24:59&#x2013;68. doi: 10.1016/j.cytogfr.2012.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2012.07.001</ArticleId><ArticleId IdType="pmc">PMC3508350</ArticleId><ArticleId IdType="pubmed">22884427</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcill&#xe1;n B, Fuentes P, Marin AV, Megino RF, Chacon-Arguedas D, Mazariegos MS, Jim&#xe9;nez-Reinoso A, Mu&#xf1;oz-Ruiz M, Laborda RG, C&#xe1;rdenas PP, et al. CD3G or CD3D knockdown in mature, but not immature, T lymphocytes similarly cripples the human TCR&#x3b1;&#x3b2; complex. Front Cell Dev Biol. 2021;9:608490. doi: 10.3389/fcell.2021.608490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.608490</ArticleId><ArticleId IdType="pmc">PMC8268008</ArticleId><ArticleId IdType="pubmed">34249896</ArticleId></ArticleIdList></Reference><Reference><Citation>Heritable gene regulation in the CD4:CD8 T cell lineage choice. Front Immunol. 2017;8:291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5360760</ArticleId><ArticleId IdType="pubmed">28382035</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P, Pandey AK, Bhattacharyya DK. Determining crucial genes associated with COVID-19 based on COPD findings&#x2736;,&#x2736;&#x2736;. Comput Biol Med. 2021;128:104126. doi: 10.1016/j.compbiomed.2020.104126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2020.104126</ArticleId><ArticleId IdType="pmc">PMC7680043</ArticleId><ArticleId IdType="pubmed">33260035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou M, Su X, Wang L, Yi X, Qiu Y, Yin X, Zhou Z, Niu X, Wang L, Su M. The molecular mechanism of multiple organ dysfunction and targeted intervention of COVID-19 based on time-order transcriptomic analysis. Front Immunol. 2021;12:729776. doi: 10.3389/fimmu.2021.729776.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.729776</ArticleId><ArticleId IdType="pmc">PMC8421734</ArticleId><ArticleId IdType="pubmed">34504502</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing Y, Luo L, Chen Y, Westerberg LS, Zhou P, Xu Z, Herrada AA, Park CS, Kubo M, Mei H, et al. SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism. Signal Transduct Target Ther. 2021;6:345. doi: 10.1038/s41392-021-00749-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00749-3</ArticleId><ArticleId IdType="pmc">PMC8456405</ArticleId><ArticleId IdType="pubmed">34552055</ArticleId></ArticleIdList></Reference><Reference><Citation>Badbaran A, Mailer RK, Dahlke C, Woens J, Fathi A, Mellinghoff SC, Renn&#xe9; T, Addo MM, Riecken K, Fehse B. Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissues. Mol Ther Methods Clin Dev. 2021;23:418&#x2013;423. doi: 10.1016/j.omtm.2021.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8566940</ArticleId><ArticleId IdType="pubmed">34786434</ArticleId></ArticleIdList></Reference><Reference><Citation>Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol. 1998;16:111&#x2013;135. doi: 10.1146/annurev.immunol.16.1.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.16.1.111</ArticleId><ArticleId IdType="pubmed">9597126</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley-Vargas RC, Gill DB, Kemper C, Liszewski MK, Atkinson JP. CD46: Expanding beyond complement regulation. Trends Immunol. 2004;25:496&#x2013;503. doi: 10.1016/j.it.2004.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2004.07.004</ArticleId><ArticleId IdType="pubmed">15324743</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundstrom K, Barh D, Uhal BD, Takayama K, Aljabali AAA, Abd El-Aziz TM, Lal A, Redwan EM, Adadi P, Chauhan G, et al. COVID-19 vaccines and thrombosis-roadblock or dead-end street? Biomolecules. 2021;11:1020. doi: 10.3390/biom11071020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11071020</ArticleId><ArticleId IdType="pmc">PMC8301964</ArticleId><ArticleId IdType="pubmed">34356644</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Goyal N, Dai L, Lin Z, Del Valle L, Zabaleta J, Liu J, Post SR, Foroozesh M, Qin Z. Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma. Blood. 2020;136:2175&#x2013;2187. doi: 10.1182/blood.2020005569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020005569</ArticleId><ArticleId IdType="pmc">PMC7645984</ArticleId><ArticleId IdType="pubmed">32518949</ArticleId></ArticleIdList></Reference><Reference><Citation>Dementyeva E, Kryukov F, Kubiczkova L, Nemec P, Sevcikova S, Ihnatova I, Jarkovsky J, Minarik J, Stefanikova Z, Kuglik P, Hajek R. Clinical implication of centrosome amplification and expression of centrosomal functional genes in multiple myeloma. J Transl Med. 2013;11:77. doi: 10.1186/1479-5876-11-77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-11-77</ArticleId><ArticleId IdType="pmc">PMC3615957</ArticleId><ArticleId IdType="pubmed">23522059</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez FO, Combes TW, Orsenigo F, Gordon S. Monocyte activation in systemic Covid-19 infection: Assay and rationale. EBioMedicine. 2020;59:102964. doi: 10.1016/j.ebiom.2020.102964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102964</ArticleId><ArticleId IdType="pmc">PMC7456455</ArticleId><ArticleId IdType="pubmed">32861199</ArticleId></ArticleIdList></Reference><Reference><Citation>Root RK, Dale DC. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: Comparisons and potential for use in the treatment of infections in nonneutropenic patients. J Infect Dis. 1999;179(Suppl 2):S342&#x2013;S352. doi: 10.1086/513857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/513857</ArticleId><ArticleId IdType="pubmed">10081506</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N, Zhao YD, Wang XM. CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients. Eur Rev Med Pharmacol Sci. 2020;24:7497&#x2013;7505.</Citation><ArticleIdList><ArticleId IdType="pubmed">32706090</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamaschi C, Terpos E, Rosati M, Angel M, Bear J, Stellas D, Karaliota S, Apostolakou F, Bagratuni T, Patseas D, et al. Systemic IL-15, IFN-&#x3b3;, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients. Cell Rep. 2021;36:109504. doi: 10.1016/j.celrep.2021.109504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109504</ArticleId><ArticleId IdType="pmc">PMC8299183</ArticleId><ArticleId IdType="pubmed">34352226</ArticleId></ArticleIdList></Reference><Reference><Citation>Du HX, Zhu JQ, Chen J, Zhou HF, Yang JH, Wan HT. Revealing the therapeutic targets and molecular mechanisms of emodin-treated coronavirus disease 2019 via a systematic study of network pharmacology. Aging (Albany NY) 2021;13:14571&#x2013;14589. doi: 10.18632/aging.203098.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203098</ArticleId><ArticleId IdType="pmc">PMC8221358</ArticleId><ArticleId IdType="pubmed">34088885</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardero M, Kovacs K, Scheithauer BW. Erythropoietin: A hormone with multiple functions. Pathobiology. 2011;78:41&#x2013;53. doi: 10.1159/000322975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000322975</ArticleId><ArticleId IdType="pubmed">21474975</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrovi&#x107; J, Pe&#x161;i&#x107; V, Lauschke VM. Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe. Eur J Hum Genet. 2020;28:88&#x2013;94. doi: 10.1038/s41431-019-0480-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-019-0480-8</ArticleId><ArticleId IdType="pmc">PMC6906321</ArticleId><ArticleId IdType="pubmed">31358955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell AM, Gale M., Jr RIG-I in RNA virus recognition. Virology. 2015;479-480:110&#x2013;121. doi: 10.1016/j.virol.2015.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.02.017</ArticleId><ArticleId IdType="pmc">PMC4424084</ArticleId><ArticleId IdType="pubmed">25749629</ArticleId></ArticleIdList></Reference><Reference><Citation>Boron WF, Boulpaep EL. Medical physiology: A cellular and molecular approach. 2nd edition. Saunders Elsevier; Philadelphia, PA: 2009.</Citation></Reference><Reference><Citation>Devreese KMJ. COVID-19-related laboratory coagulation findings. Int J Lab Hematol. 2021;43(Suppl 1):S36&#x2013;S42. doi: 10.1111/ijlh.13547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijlh.13547</ArticleId><ArticleId IdType="pmc">PMC8444785</ArticleId><ArticleId IdType="pubmed">34288440</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel KR, Roberts JT, Barb AW. Multiple variables at the leukocyte cell surface impact Fc &#x3b3; receptor-dependent mechanisms. Front Immunol. 2019;10:223. doi: 10.3389/fimmu.2019.00223.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00223</ArticleId><ArticleId IdType="pmc">PMC6382684</ArticleId><ArticleId IdType="pubmed">30837990</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelton JG, Smith JW, Santos AV, Murphy WG, Horsewood P. Platelet IgG Fc receptor. Am J Hematol. 1987;25:299&#x2013;310. doi: 10.1002/ajh.2830250310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.2830250310</ArticleId><ArticleId IdType="pubmed">3605076</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao J, Al-Tamimi M, Baker RI, Andrews RK, Gardiner EE. The platelet Fc receptor, Fc&#x3b3;RIIa. Immunol Rev. 2015;268:241&#x2013;252. doi: 10.1111/imr.12370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12370</ArticleId><ArticleId IdType="pubmed">26497525</ArticleId></ArticleIdList></Reference><Reference><Citation>Fearon DT, Carroll MC. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol. 2000;18:393&#x2013;422. doi: 10.1146/annurev.immunol.18.1.393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.18.1.393</ArticleId><ArticleId IdType="pubmed">10837064</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartwig JH, Barkalow K, Azim A, Italiano J. The elegant platelet: Signals controlling actin assembly. Thromb Haemost. 1999;82:392&#x2013;398. doi: 10.1055/s-0037-1615858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1615858</ArticleId><ArticleId IdType="pubmed">10605729</ArticleId></ArticleIdList></Reference><Reference><Citation>Viertlboeck BC, Schweinsberg S, Hanczaruk MA, Schmitt R, Du Pasquier L, Herberg FW, G&#xf6;bel TW. The chicken leukocyte receptor complex encodes a primordial, activating, high-affinity IgY Fc receptor. Proc Natl Acad Sci USA. 2007;104:11718&#x2013;11723. doi: 10.1073/pnas.0702011104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0702011104</ArticleId><ArticleId IdType="pmc">PMC1913898</ArticleId><ArticleId IdType="pubmed">17606923</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y, Tang F. SARS-CoV-2-mediated immune system activation and potential application in immunotherapy. Med Res Rev. 2021;41:1167&#x2013;1194. doi: 10.1002/med.21756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21756</ArticleId><ArticleId IdType="pubmed">33185926</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss KM, Clark NM, Olivares-Navarrete R. Macrophage response to hydrophilic biomaterials regulates MSC recruitment and T-helper cell populations. Biomaterials. 2018;182:202&#x2013;215. doi: 10.1016/j.biomaterials.2018.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2018.08.029</ArticleId><ArticleId IdType="pubmed">30138783</ArticleId></ArticleIdList></Reference><Reference><Citation>Springer S, Menzel LM, Zieger M. Google trends provides a tool to monitor population concerns and information needs during COVID-19 pandemic. Brain Behav Immun. 2020;87:109&#x2013;110. doi: 10.1016/j.bbi.2020.04.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.073</ArticleId><ArticleId IdType="pmc">PMC7189190</ArticleId><ArticleId IdType="pubmed">32360607</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockmeyer NH, Potthoff A, Kasper A, Nabring C, J&#xf6;ckel KH, Siffert W. GNB3 C825T polymorphism and response to anti-retroviral combination therapy in HIV-1-infected patients-a pilot study. Eur J Med Res. 2005;10:489&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pubmed">16354603</ArticleId></ArticleIdList></Reference><Reference><Citation>Uddin MN, Akter R, Li M, Abdelrahman Z. Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles. Chem Biol Interact. 2021;335:109370. doi: 10.1016/j.cbi.2021.109370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2021.109370</ArticleId><ArticleId IdType="pmc">PMC7833036</ArticleId><ArticleId IdType="pubmed">33422520</ArticleId></ArticleIdList></Reference><Reference><Citation>Bieberich F, Vazquez-Lombardi R, Yermanos A, Ehling RA, Mason DM, Wagner B, Kapetanovic E, Di Roberto RB, Weber CR, Savic M, et al. A single-cell atlas of lymphocyte adaptive immune repertoires and transcriptomes reveals age-related differences in convalescent COVID-19 patients. Front Immunol. 2021;12:701085. doi: 10.3389/fimmu.2021.701085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.701085</ArticleId><ArticleId IdType="pmc">PMC8312723</ArticleId><ArticleId IdType="pubmed">34322127</ArticleId></ArticleIdList></Reference><Reference><Citation>Fricke-Galindo I, Falf&#xe1;n-Valencia R. Genetics insight for COVID-19 susceptibility and severity: A review. Front Immunol. 2021;12:622176. doi: 10.3389/fimmu.2021.622176.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.622176</ArticleId><ArticleId IdType="pmc">PMC8047200</ArticleId><ArticleId IdType="pubmed">33868239</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z, Wei F, Zhang Y, Wang T, Gao W, Yu S, Sun H, Pu J, Sun Y, Wang M, et al. IFI16 directly senses viral RNA and enhances RIG-I transcription and activation to restrict influenza virus infection. Nat Microbiol. 2021;6:932&#x2013;945. doi: 10.1038/s41564-021-00907-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00907-x</ArticleId><ArticleId IdType="pubmed">33986530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy RB, Poland GA, Ovsyannikova IG, Oberg AL, Asmann YW, Grill DE, Vierkant RA, Jacobson RM. Impaired innate, humoral, and cellular immunity despite a take in smallpox vaccine recipients. Vaccine. 2016;34:3283&#x2013;3290. doi: 10.1016/j.vaccine.2016.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.05.005</ArticleId><ArticleId IdType="pmc">PMC5528000</ArticleId><ArticleId IdType="pubmed">27177944</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotenko SV. IFN-&#x3bb;s. Curr Opin Immunol. 2011;23:583&#x2013;590. doi: 10.1016/j.coi.2011.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2011.07.007</ArticleId><ArticleId IdType="pmc">PMC3196341</ArticleId><ArticleId IdType="pubmed">21840693</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu UI, Holland SM. Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis. 2015;15:968&#x2013;980. doi: 10.1016/S1473-3099(15)00089-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00089-4</ArticleId><ArticleId IdType="pubmed">26049967</ArticleId></ArticleIdList></Reference><Reference><Citation>Voloudakis G, Hoffman G, Venkatesh S, Lee KM, Dobrindt K, Vicari JM, Zhang W, Beckmann ND, Jiang S, Hoagland D, et al. IL10RB as a key regulator of COVID-19 host susceptibility and severity. medRxiv. doi: 10.1101/2021.05.31.21254851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.31.21254851</ArticleId></ArticleIdList></Reference><Reference><Citation>Vecchi&#xe9; A, Bonaventura A, Toldo S, Dagna L, Dinarello CA, Abbate A. IL-18 and infections: Is there a role for targeted therapies. J Cell Physiol. 2021;236:1638&#x2013;1657. doi: 10.1002/jcp.30008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.30008</ArticleId><ArticleId IdType="pubmed">32794180</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters VA, Joesting JJ, Freund GG. IL-1 receptor 2 (IL-1R2) and its role in immune regulation. Brain Behav Immun. 2013;32:1&#x2013;8. doi: 10.1016/j.bbi.2012.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2012.11.006</ArticleId><ArticleId IdType="pmc">PMC3610842</ArticleId><ArticleId IdType="pubmed">23195532</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;nard A, Jacobsen A, Brunner M, Krautz C, Kl&#xf6;sch B, Swierzy I, Naschberger E, Podolska MJ, Kouhestani D, David P, et al. Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections. Nat Commun. 2021;12:1112. doi: 10.1038/s41467-021-21310-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21310-4</ArticleId><ArticleId IdType="pmc">PMC7893044</ArticleId><ArticleId IdType="pubmed">33602937</ArticleId></ArticleIdList></Reference><Reference><Citation>Zizzo G, Cohen PL. Imperfect storm: Is interleukin-33 the Achilles heel of COVID-19? Lancet Rheumatol. 2020;12:e779&#x2013;e790. doi: 10.1016/S2665-9913(20)30340-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30340-4</ArticleId><ArticleId IdType="pmc">PMC7546716</ArticleId><ArticleId IdType="pubmed">33073244</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh PT, Fallon PG. The emergence of the IL-36 cytokine family as novel targets for inflammatory diseases. Ann NY Acad Sci. 2018;1417:23&#x2013;34. doi: 10.1111/nyas.13280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.13280</ArticleId><ArticleId IdType="pubmed">27783881</ArticleId></ArticleIdList></Reference><Reference><Citation>Nussbaum JC, Van Dyken SJ, von Moltke J, Cheng LE, Mohapatra A, Molofsky AB, Thornton EE, Krummel MF, Chawla A, Liang HE, Locksley RM. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature. 2013;502:245&#x2013;248. doi: 10.1038/nature12526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12526</ArticleId><ArticleId IdType="pmc">PMC3795960</ArticleId><ArticleId IdType="pubmed">24037376</ArticleId></ArticleIdList></Reference><Reference><Citation>Coomes EA, Haghbayan H. Interleukin-6 in Covid-19: A systematic review and meta-analysis. Rev Med Virol. 2020;30:1&#x2013;9. doi: 10.1002/rmv.2141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2141</ArticleId><ArticleId IdType="pmc">PMC7460877</ArticleId><ArticleId IdType="pubmed">32845568</ArticleId></ArticleIdList></Reference><Reference><Citation>Das UN. Bioactive lipids in COVID-19-further evidence. Arch Med Res. 2021;52:107&#x2013;120. doi: 10.1016/j.arcmed.2020.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2020.09.006</ArticleId><ArticleId IdType="pmc">PMC7480223</ArticleId><ArticleId IdType="pubmed">32981754</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam ABMMK, Khan MA, Ahmed R, Hossain MS, Kabir SMT, Islam MS, Siddiki AMAMZ. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2. J Transl Med. 2021;19:32. doi: 10.1186/s12967-020-02695-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02695-0</ArticleId><ArticleId IdType="pmc">PMC7790360</ArticleId><ArticleId IdType="pubmed">33413422</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien JR. Shear-induced platelet aggregation. Lancet. 1990;335:711&#x2013;713. doi: 10.1016/0140-6736(90)90815-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(90)90815-M</ArticleId><ArticleId IdType="pubmed">1969070</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmuir P, Yeleswaram S, Smith P, Knorr B, Squier P. Design of clinical trials evaluating ruxolitinib, a JAK1/JAK2 inhibitor, for treatment of COVID-19-associated cytokine storm. Dela J Public Health. 2020;6:50&#x2013;54. doi: 10.32481/djph.2020.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.32481/djph.2020.07.015</ArticleId><ArticleId IdType="pmc">PMC8389815</ArticleId><ArticleId IdType="pubmed">34467111</ArticleId></ArticleIdList></Reference><Reference><Citation>Melman YF, Krummerman A, McDonald TV. KCNE regulation of KvLQT1 channels: Structure-function correlates. Trends Cardiovasc Med. 2002;12:182&#x2013;187. doi: 10.1016/S1050-1738(02)00158-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1050-1738(02)00158-5</ArticleId><ArticleId IdType="pubmed">12069759</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouas L, Nicaud V, Berthet M, Forhan A, Tiret L, Balkau B, Guicheney P, D.E.S.I.R. Study Group Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. Eur J Hum Genet. 2005;13:1213&#x2013;1222. doi: 10.1038/sj.ejhg.5201489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ejhg.5201489</ArticleId><ArticleId IdType="pubmed">16132053</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Acampa M, Laghi-Pasini F, Bertolozzi I, Finizola F, Vanni F, Natale M, Bisogno S, Cevenini G, Cartocci A, et al. Cardiac arrest risk during acute infections: Systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression. Circ Arrhythm Electrophysiol. 2020;13:e008627. doi: 10.1161/CIRCEP.120.008627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.120.008627</ArticleId><ArticleId IdType="pubmed">32654514</ArticleId></ArticleIdList></Reference><Reference><Citation>Szendrey M, Guo J, Li W, Yang T, Zhang S. COVID-19 drugs chloroquine and hydroxychloroquine, but not azithromycin and remdesivir, block hERG potassium channels. J Pharmacol Exp Ther. 2021;377:265&#x2013;272. doi: 10.1124/jpet.120.000484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.120.000484</ArticleId><ArticleId IdType="pubmed">33674391</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahl SL, Woodworth JS, Lerche CJ, Cramer EP, Nielsen PR, Moser C, Thomsen AR, Borregaard N, Cowland JB. Lipocalin-2 functions as inhibitor of innate resistance to mycobacterium tuberculosis. Front Immunol. 2018;9:2717. doi: 10.3389/fimmu.2018.02717.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02717</ArticleId><ArticleId IdType="pmc">PMC6275245</ArticleId><ArticleId IdType="pubmed">30534124</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: Integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 2002;4:157&#x2013;164. doi: 10.1186/ar401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar401</ArticleId><ArticleId IdType="pmc">PMC128926</ArticleId><ArticleId IdType="pubmed">12010565</ArticleId></ArticleIdList></Reference><Reference><Citation>Jab&#x142;o&#x144;ska-Trypu&#x107; A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016;31(Suppl 1):S177&#x2013;S183. doi: 10.3109/14756366.2016.1161620.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14756366.2016.1161620</ArticleId><ArticleId IdType="pubmed">27028474</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisano TJ, Hakkinen I, Rybinnik I. Large vessel occlusion secondary to COVID-19 hypercoagulability in a young patient: A case report and literature review. J Stroke Cerebrovasc Dis. 2020;29:105307. doi: 10.1016/j.jstrokecerebrovasdis.2020.105307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.105307</ArticleId><ArticleId IdType="pmc">PMC7832635</ArticleId><ArticleId IdType="pubmed">32992201</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolidis SA, Kakara M, Painter MM, Goel RR, Mathew D, Lenzi K, Rezk A, Patterson KR, Espinoza DA, Kadri JC, et al. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy. Nat Med. 2021;27:1990&#x2013;2001. doi: 10.1038/s41591-021-01507-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01507-2</ArticleId><ArticleId IdType="pmc">PMC8604727</ArticleId><ArticleId IdType="pubmed">34522051</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu W, Liu X, Wang T, Liu F, Zhu A, Lin Y, Luo J, Ye F, He J, Zhao J, et al. Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients. J Med Virol. 2021;93:582&#x2013;584. doi: 10.1002/jmv.26406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26406</ArticleId><ArticleId IdType="pmc">PMC7436726</ArticleId><ArticleId IdType="pubmed">32776556</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, Kritas SK. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): Anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34:327&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">32171193</ArticleId></ArticleIdList></Reference><Reference><Citation>Morsy S. NCAM protein and SARS-COV-2 surface proteins: In-silico hypothetical evidence for the immunopathogenesis of Guillain-Barr&#xe9; syndrome. Med Hypotheses. 2020;145:110342. doi: 10.1016/j.mehy.2020.110342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110342</ArticleId><ArticleId IdType="pmc">PMC7543761</ArticleId><ArticleId IdType="pubmed">33069093</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R. Innate receptor activation patterns involving TLR and NLR synergisms in COVID-19, ALI/ARDS and sepsis cytokine storms: A review and model making novel predictions and therapeutic suggestions. Int J Mol Sci. 2021;22:2108. doi: 10.3390/ijms22042108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22042108</ArticleId><ArticleId IdType="pmc">PMC7924650</ArticleId><ArticleId IdType="pubmed">33672738</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol. 2004;5:800&#x2013;808. doi: 10.1038/ni1092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1092</ArticleId><ArticleId IdType="pubmed">15220916</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito E, Cuzzocrea S. The role of nitric oxide synthases in lung inflammation. Curr Opin Investig Drugs. 2007;8:899&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">17979023</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamkrelidze M, Intskirveli N, Vardosanidze K, Goliadze L, Chikhladze KH, Ratiani L. Myocardial dysfunction during septic shock (review) Georgian Med News. 2014;237:40&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">25617099</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang X, Li S, Zhao Y, Chen K, Wang X, Song W, Ma J, Tu X, Xia Y, Zhang S, Gao C. Systematic meta-analysis of the association between a common NOS1AP genetic polymorphism, the QTc interval, and sudden death. Int Heart J. 2019;60:1083&#x2013;1090. doi: 10.1536/ihj.19-024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.19-024</ArticleId><ArticleId IdType="pubmed">31447468</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan SP, Seet RCS, Kennedy BK. Does eNOS derived nitric oxide protect the young from severe COVID-19 complications. Ageing Res Rev. 2020;64:101201. doi: 10.1016/j.arr.2020.101201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2020.101201</ArticleId><ArticleId IdType="pmc">PMC7609225</ArticleId><ArticleId IdType="pubmed">33157320</ArticleId></ArticleIdList></Reference><Reference><Citation>Thom SR, Fisher D, Xu YA, Garner S, Ischiropoulos H. Role of nitric oxide-derived oxidants in vascular injury from carbon monoxide in the rat. Am J Physiol. 1999;276:H984&#x2013;H992.</Citation><ArticleIdList><ArticleId IdType="pubmed">10070083</ArticleId></ArticleIdList></Reference><Reference><Citation>Valent A, Danglot G, Bernheim A. Mapping of the tyrosine kinase receptors trkA (NTRK1), trkB (NTRK2) and trkC(NTRK3) to human chromosomes 1q22, 9q22 and 15q25 by fluorescence in situ hybridization. Eur J Hum Genet. 1997;5:102&#x2013;104. doi: 10.1159/000484742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000484742</ArticleId><ArticleId IdType="pubmed">9195161</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Chen L, Zhu J, Rodgers GP. The glycoprotein hGC-1 binds to cadherin and lectins. Exp Cell Res. 2006;312:1785&#x2013;1797. doi: 10.1016/j.yexcr.2006.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2006.02.011</ArticleId><ArticleId IdType="pubmed">16566923</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennigs JK, L&#xfc;neburg N, Stage A, Schmitz M, K&#xf6;rbelin J, Harbaum L, Matuszcak C, Mienert J, Bokemeyer C, B&#xf6;ger RH, et al. The P2-receptor-mediated Ca2+ signalosome of the human pulmonary endothelium-implications for pulmonary arterial hypertension. Purinergic Signal. 2019;15:299&#x2013;311. doi: 10.1007/s11302-019-09674-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-019-09674-1</ArticleId><ArticleId IdType="pmc">PMC6737170</ArticleId><ArticleId IdType="pubmed">31396838</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo MV, McGavern DB. Immune surveillance of the CNS following infection and injury. Trends Immunol. 2015;36:637&#x2013;650. doi: 10.1016/j.it.2015.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2015.08.002</ArticleId><ArticleId IdType="pmc">PMC4592776</ArticleId><ArticleId IdType="pubmed">26431941</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuuminen R, Nyk&#xe4;nen A, Ker&#xe4;nen MA, Krebs R, Alitalo K, Koskinen PK, Lemstr&#xf6;m KB. The effect of platelet-derived growth factor ligands in rat cardiac allograft vasculopathy and fibrosis. Transplant Proc. 2006;38:3271&#x2013;3273. doi: 10.1016/j.transproceed.2006.10.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transproceed.2006.10.056</ArticleId><ArticleId IdType="pubmed">17175246</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum E, Margalit R, Levy L, Getter T, Lahav R, Zilber S, Bradfield P, Imhof BA, Alpert E, Gruzman A. A Potent leukocyte transmigration blocker: GT-73 showed a protective effect against LPS-induced ARDS in mice. Molecules. 2021;26:4583. doi: 10.3390/molecules26154583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26154583</ArticleId><ArticleId IdType="pmc">PMC8348436</ArticleId><ArticleId IdType="pubmed">34361736</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovina N, Akinosoglou K, Eugen-Olsen J, Hayek S, Reiser J, Giamarellos-Bourboulis EJ. Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia. Crit Care. 2020;24:187. doi: 10.1186/s13054-020-02897-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02897-4</ArticleId><ArticleId IdType="pmc">PMC7191969</ArticleId><ArticleId IdType="pubmed">32354367</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Jain A, Choi SW, da Silva GPD, Allers L, Mudd MH, Peters RS, Anonsen JH, Rusten TE, Lazarou M, Deretic V. Mammalian Atg8 proteins and the autophagy factor IRGM control mTOR and TFEB at a regulatory node critical for responses to pathogens. Nat Cell Biol. 2020;22:973&#x2013;985. doi: 10.1038/s41556-020-0549-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-020-0549-1</ArticleId><ArticleId IdType="pmc">PMC7482486</ArticleId><ArticleId IdType="pubmed">32753672</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoxha M. What about COVID-19 and arachidonic acid pathway. Eur J Clin Pharmacol. 2020;76:1501&#x2013;1504. doi: 10.1007/s00228-020-02941-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-020-02941-w</ArticleId><ArticleId IdType="pmc">PMC7314570</ArticleId><ArticleId IdType="pubmed">32583353</ArticleId></ArticleIdList></Reference><Reference><Citation>Keikha M, Ghazvini K, Eslami M, Yousefi B, Casseb J, Yousefi M, Karbalaei M. Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection. Microb Pathog. 2020;144:104198. doi: 10.1016/j.micpath.2020.104198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2020.104198</ArticleId><ArticleId IdType="pubmed">32283259</ArticleId></ArticleIdList></Reference><Reference><Citation>Coggeshall KM. Negative signaling in health and disease. Immunol Res. 1999;19:47&#x2013;64. doi: 10.1007/BF02786476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02786476</ArticleId><ArticleId IdType="pubmed">10374695</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza JG, Starobinas N, Iba&#xf1;ez O. Unknown/enigmatic functions of extracellular ASC. Immunology. 2021;163:377&#x2013;388. doi: 10.1111/imm.13375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13375</ArticleId><ArticleId IdType="pmc">PMC8274145</ArticleId><ArticleId IdType="pubmed">34042182</ArticleId></ArticleIdList></Reference><Reference><Citation>Larabi A, Barnich N, Nguyen HTT. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD. Autophagy. 2020;16:38&#x2013;51. doi: 10.1080/15548627.2019.1635384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1635384</ArticleId><ArticleId IdType="pmc">PMC6984609</ArticleId><ArticleId IdType="pubmed">31286804</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MJ. Renin: Friend or foe? Heart. 2007;93:1026&#x2013;1033. doi: 10.1136/hrt.2006.107706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2006.107706</ArticleId><ArticleId IdType="pmc">PMC1955008</ArticleId><ArticleId IdType="pubmed">17488768</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R, Rahimi N. COVID-19, renin-angiotensin system and endothelial dysfunction. Cells. 2020;9:1652. doi: 10.3390/cells9071652.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9071652</ArticleId><ArticleId IdType="pmc">PMC7407648</ArticleId><ArticleId IdType="pubmed">32660065</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanatori I, Yasui Y, Noguchi Y, Kishi F. Inhibition of iron uptake by ferristatin II is exerted through internalization of DMT1 at the plasma membrane. Cell Biol Int. 2015;39:427&#x2013;434. doi: 10.1002/cbin.10403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.10403</ArticleId><ArticleId IdType="pubmed">25491917</ArticleId></ArticleIdList></Reference><Reference><Citation>Denham NC, Pearman CM, Ding WY, Waktare J, Gupta D, Snowdon R, Hall M, Cooper R, Modi S, Todd D, Mahida S. Systematic re-evaluation of SCN5A variants associated with Brugada syndrome. J Cardiovasc Electrophysiol. 2019;30:118&#x2013;127. doi: 10.1111/jce.13740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.13740</ArticleId><ArticleId IdType="pubmed">30203441</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadja DM, Guerin CL, Chocron R, Yatim N, Boussier J, Gendron N, Khider L, Hadjadj J, Goudot G, Debuc B, et al. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. 2020;23:611&#x2013;620. doi: 10.1007/s10456-020-09730-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-020-09730-0</ArticleId><ArticleId IdType="pmc">PMC7250589</ArticleId><ArticleId IdType="pubmed">32458111</ArticleId></ArticleIdList></Reference><Reference><Citation>Bongiovanni D, Klug M, Lazareva O, Weidlich S, Biasi M, Ursu S, Warth S, Buske C, Lukas M, Spinner CD, et al. SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype. Cell Death Dis. 2021;12:50. doi: 10.1038/s41419-020-03333-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-03333-9</ArticleId><ArticleId IdType="pmc">PMC7790351</ArticleId><ArticleId IdType="pubmed">33414384</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, Yang XO. Dysregulation of pulmonary responses in severe COVID-19. Viruses. 2021;13:957. doi: 10.3390/v13060957.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13060957</ArticleId><ArticleId IdType="pmc">PMC8224314</ArticleId><ArticleId IdType="pubmed">34064104</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzen J, Beers MF. Contributions of alveolar epithelial cell quality control to pulmonary fibrosis. J Clin Invest. 2020;130:5088&#x2013;5099. doi: 10.1172/JCI139519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI139519</ArticleId><ArticleId IdType="pmc">PMC7524463</ArticleId><ArticleId IdType="pubmed">32870817</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandy D, Sharma N, Senapati S. Systematic review and meta-analysis confirms significant contribution of surfactant protein D in chronic obstructive pulmonary disease. Front Genet. 2019;10:339. doi: 10.3389/fgene.2019.00339.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00339</ArticleId><ArticleId IdType="pmc">PMC6479180</ArticleId><ArticleId IdType="pubmed">31057601</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lisa F, Kaludercic N, Carpi A, Menab&#xf2; R, Giorgio M. Mitochondria and vascular pathology. Pharmacol Rep. 2009;61:123&#x2013;130. doi: 10.1016/S1734-1140(09)70014-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1734-1140(09)70014-3</ArticleId><ArticleId IdType="pubmed">19307700</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinarello CA, Nold-Petry C, Nold M, Fujita M, Li S, Kim S, Bufler P. Suppression of innate inflammation and immunity by interleukin-37. Eur J Immunol. 2016;46:1067&#x2013;1081. doi: 10.1002/eji.201545828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201545828</ArticleId><ArticleId IdType="pmc">PMC5003108</ArticleId><ArticleId IdType="pubmed">27060871</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalbetti N, Simonin A, Kovacs G, Hediger MA. Mammalian iron transporters: families SLC11 and SLC40. Mol Aspects Med. 2013;34:270&#x2013;287. doi: 10.1016/j.mam.2013.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2013.01.002</ArticleId><ArticleId IdType="pubmed">23506870</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulert GS, Blum SA, Cron RQ. Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children. Curr Opin Pediatr. 2021;33:549&#x2013;555. doi: 10.1097/MOP.0000000000001061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000001061</ArticleId><ArticleId IdType="pmc">PMC8571059</ArticleId><ArticleId IdType="pubmed">34534994</ArticleId></ArticleIdList></Reference><Reference><Citation>Pachlopnik Schmid J, de Saint Basile G. Angeborene h&#xe4;mophagozytische lymphohistiozytose (HLH) Klin Padiatr. 2010;222:345&#x2013;350. doi: 10.1055/s-0029-1246165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0029-1246165</ArticleId><ArticleId IdType="pubmed">20458667</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi JH, Xie X, Sun SC. TBK1 as a regulator of autoimmunity and antitumor immunity. Cell Mol Immunol. 2018;15:743&#x2013;745. doi: 10.1038/cmi.2017.165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2017.165</ArticleId><ArticleId IdType="pmc">PMC6141483</ArticleId><ArticleId IdType="pubmed">29503440</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimecki M, Actor JK, Kruzel ML. The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm. Int Immunopharmacol. 2021;95:107571. doi: 10.1016/j.intimp.2021.107571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107571</ArticleId><ArticleId IdType="pmc">PMC7953442</ArticleId><ArticleId IdType="pubmed">33765614</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabot PR, Raiola L, Lussier-Price M, Morse T, Arseneault G, Archambault J, Omichinski JG. Structural and functional characterization of a complex between the acidic transactivation domain of EBNA2 and the Tfb1/p62 subunit of TFIIH. PLoS Pathog. 2014;10:e1004042. doi: 10.1371/journal.ppat.1004042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004042</ArticleId><ArticleId IdType="pmc">PMC3968163</ArticleId><ArticleId IdType="pubmed">24675874</ArticleId></ArticleIdList></Reference><Reference><Citation>Speeckaert MM, Speeckaert R, Delanghe JR. Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci. 2010;47:213&#x2013;228. doi: 10.3109/10408363.2010.550461.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10408363.2010.550461</ArticleId><ArticleId IdType="pubmed">21391831</ArticleId></ArticleIdList></Reference><Reference><Citation>Bg S, Gosavi S, Ananda Rao A, Shastry S, Raj SC, Sharma A, Suresh A, Noubade R. Neutrophil-to-lymphocyte, lymphocyte-to-monocyte, and platelet-to-lymphocyte ratios: Prognostic significance in COVID-19. Cureus. 2021;13:e12622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875321</ArticleId><ArticleId IdType="pubmed">33585111</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell GR, To RK, Hanna J, Spector SA. SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway. iScience. 2021;24:102295. doi: 10.1016/j.isci.2021.102295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102295</ArticleId><ArticleId IdType="pmc">PMC7939994</ArticleId><ArticleId IdType="pubmed">33718825</ArticleId></ArticleIdList></Reference><Reference><Citation>Borrello S, Nicol&#xf2; C, Delogu G, Pandolfi F, Ria F. TLR2: a crossroads between infections and autoimmunity. Int J Immunopathol Pharmacol. 2011;24:549&#x2013;556. doi: 10.1177/039463201102400301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/039463201102400301</ArticleId><ArticleId IdType="pubmed">21978687</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M, Karki R, Williams EP, Yang D, Fitzpatrick E, Vogel P, Jonsson CB, Kanneganti TD. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol. 2021;22:829&#x2013;838. doi: 10.1038/s41590-021-00937-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00937-x</ArticleId><ArticleId IdType="pmc">PMC8882317</ArticleId><ArticleId IdType="pubmed">33963333</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S, Shafiei M, Longoria C, Schoggins JW, Savani R, Zaki H. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-&#x3ba;B pathway. Elife. 2021;10:e68563. doi: 10.7554/eLife.68563.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.68563</ArticleId><ArticleId IdType="pmc">PMC8709575</ArticleId><ArticleId IdType="pubmed">34866574</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn KM, Lee SG, Kim HJ, Cheon S, Jeong H, Lee J, Kim IS, Silwal P, Kim YJ, Paik S, et al. COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis. J Korean Med Sci. 2020;35:e343. doi: 10.3346/jkms.2020.35.e343.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e343</ArticleId><ArticleId IdType="pmc">PMC7521960</ArticleId><ArticleId IdType="pubmed">32989935</ArticleId></ArticleIdList></Reference><Reference><Citation>Guven-Maiorov E, Keskin O, Gursoy A, VanWaes C, Chen Z, Tsai CJ, Nussinov R. TRAF3 signaling: Competitive binding and evolvability of adaptive viral molecular mimicry. Biochim Biophys Acta. 2016;1860:2646&#x2013;2655. doi: 10.1016/j.bbagen.2016.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2016.05.021</ArticleId><ArticleId IdType="pmc">PMC7117012</ArticleId><ArticleId IdType="pubmed">27208423</ArticleId></ArticleIdList></Reference><Reference><Citation>Callaway E. The quest to find genes that drive severe COVID. Nature. 2021;595:346&#x2013;348. doi: 10.1038/d41586-021-01827-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01827-w</ArticleId><ArticleId IdType="pubmed">34239118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur S, Tripathi DM, Yadav A. The enigma of endothelium in COVID-19. Front Physiol. 2020;11:989. doi: 10.3389/fphys.2020.00989.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00989</ArticleId><ArticleId IdType="pmc">PMC7417426</ArticleId><ArticleId IdType="pubmed">32848893</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovas A, Osiaevi I, Buscher K, Sackarnd J, Tepasse PR, Fobker M, K&#xfc;hn J, Braune S, G&#xf6;bel U, Th&#xf6;lking G, et al. Microvascular dysfunction in COVID-19: The MYSTIC study. Angiogenesis. 2021;24:145&#x2013;157. doi: 10.1007/s10456-020-09753-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-020-09753-7</ArticleId><ArticleId IdType="pmc">PMC7556767</ArticleId><ArticleId IdType="pubmed">33058027</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb D, Alexaki A, Hernandez N, Hunt R, Laurie K, Kames J, Hamasaki-Katagiri N, Komar AA, DiCuccio M, Kimchi-Sarfaty C. Gene variants of coagulation related proteins that interact with SARS-CoV-2. PLoS Comput Biol. 2021;17:e1008805. doi: 10.1371/journal.pcbi.1008805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1008805</ArticleId><ArticleId IdType="pmc">PMC8007013</ArticleId><ArticleId IdType="pubmed">33730015</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahidi M. Thrombosis and von Willebrand factor. Adv Exp Med Biol. 2017;906:285&#x2013;306. doi: 10.1007/5584_2016_122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/5584_2016_122</ArticleId><ArticleId IdType="pubmed">27628010</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>